Effects of third generation aromatase inhibitors on bone health and other safety parameters: Results of an open, randomised, multi-centre study of letrozole, exemestane and anastrozole in healthy postmenopausal women

Further, long-term clinical studies are required to determine the impact, if any, of the differences observed between the AIs.